Protagonist Therapeutics Stock Market Value
| PTGX Stock | USD 54.78 0.12 0.22% |
| Symbol | Protagonist |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Protagonist Therapeutics. If investors know Protagonist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Protagonist Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Protagonist Therapeutics is measured differently than its book value, which is the value of Protagonist that is recorded on the company's balance sheet. Investors also form their own opinion of Protagonist Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Protagonist Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Protagonist Therapeutics' market value can be influenced by many factors that don't directly affect Protagonist Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Protagonist Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Protagonist Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Protagonist Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Protagonist Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Protagonist Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Protagonist Therapeutics.
| 12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in Protagonist Therapeutics on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding Protagonist Therapeutics or generate 0.0% return on investment in Protagonist Therapeutics over 90 days. Protagonist Therapeutics is related to or competes with Revolution Medicines, Akero Therapeutics, Avidity Biosciences, Stoke Therapeutics, Kura Oncology, Merus BV, and Replimune. Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to a... More
Protagonist Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Protagonist Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Protagonist Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.82 | |||
| Information Ratio | 0.1128 | |||
| Maximum Drawdown | 50.66 | |||
| Value At Risk | (3.74) | |||
| Potential Upside | 3.48 |
Protagonist Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Protagonist Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Protagonist Therapeutics' standard deviation. In reality, there are many statistical measures that can use Protagonist Therapeutics historical prices to predict the future Protagonist Therapeutics' volatility.| Risk Adjusted Performance | 0.0936 | |||
| Jensen Alpha | 0.4701 | |||
| Total Risk Alpha | 1.44 | |||
| Sortino Ratio | 0.2602 | |||
| Treynor Ratio | (0.44) |
Protagonist Therapeutics Backtested Returns
Protagonist Therapeutics appears to be not too volatile, given 3 months investment horizon. Protagonist Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0976, which implies the firm had a 0.0976 % return per unit of risk over the last 3 months. By analyzing Protagonist Therapeutics' technical indicators, you can evaluate if the expected return of 0.63% is justified by implied risk. Please evaluate Protagonist Therapeutics' Coefficient Of Variation of 1024.71, semi deviation of 2.43, and Risk Adjusted Performance of 0.0936 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Protagonist Therapeutics holds a performance score of 7. The company holds a Beta of -1.41, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Protagonist Therapeutics are expected to decrease by larger amounts. On the other hand, during market turmoil, Protagonist Therapeutics is expected to outperform it. Please check Protagonist Therapeutics' potential upside, as well as the relationship between the accumulation distribution and price action indicator , to make a quick decision on whether Protagonist Therapeutics' historical price patterns will revert.
Auto-correlation | -0.02 |
Very weak reverse predictability
Protagonist Therapeutics has very weak reverse predictability. Overlapping area represents the amount of predictability between Protagonist Therapeutics time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Protagonist Therapeutics price movement. The serial correlation of -0.02 indicates that only 2.0% of current Protagonist Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.02 | |
| Spearman Rank Test | -0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 26.83 |
Protagonist Therapeutics lagged returns against current returns
Autocorrelation, which is Protagonist Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Protagonist Therapeutics' stock expected returns. We can calculate the autocorrelation of Protagonist Therapeutics returns to help us make a trade decision. For example, suppose you find that Protagonist Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Protagonist Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Protagonist Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Protagonist Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Protagonist Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Protagonist Therapeutics Lagged Returns
When evaluating Protagonist Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Protagonist Therapeutics stock have on its future price. Protagonist Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Protagonist Therapeutics autocorrelation shows the relationship between Protagonist Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Protagonist Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Protagonist Stock Analysis
When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.